share_log

BioVie | PRE 14A: Preliminary proxy statements relating to merger or acquisition

BioVie | PRE 14A: Preliminary proxy statements relating to merger or acquisition

BioVie | PRE 14A：並購重組委托聲明
美股SEC公告 ·  2024/09/18 06:00

Moomoo AI 已提取核心訊息

BioVie Inc., a Nevada corporation, announced the filing of a PRE 14A preliminary proxy statement with the SEC, detailing the upcoming virtual Annual Meeting of Stockholders scheduled for November 7, 2024. The meeting will address the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the 2025 fiscal year, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan. The Board of Directors has recommended voting in favor of all proposals. Stockholders of record as of September 30, 2024, are entitled to participate and vote at the meeting, which will be conducted online due to the inability to attend in person. The proxy materials, including the 2024 Annual Report and Proxy Statement, will be available on BioVie's website and mailed to stockholders around October 9, 2024.
BioVie Inc., a Nevada corporation, announced the filing of a PRE 14A preliminary proxy statement with the SEC, detailing the upcoming virtual Annual Meeting of Stockholders scheduled for November 7, 2024. The meeting will address the election of six directors, the ratification of EisnerAmper LLP as the independent registered public accounting firm for the 2025 fiscal year, an advisory vote on executive compensation, and the approval of an amendment to the 2019 Omnibus Equity Incentive Plan. The Board of Directors has recommended voting in favor of all proposals. Stockholders of record as of September 30, 2024, are entitled to participate and vote at the meeting, which will be conducted online due to the inability to attend in person. The proxy materials, including the 2024 Annual Report and Proxy Statement, will be available on BioVie's website and mailed to stockholders around October 9, 2024.
biovie公司，一家內華達州註冊公司，宣佈向證券交易委員會提交了一份預先14A初步代理聲明，詳細介紹了定於2024年11月7日舉行的即將召開的股東年會。會議將討論選舉六名董事，確認EisnerAmper LLP爲2025財年的獨立註冊會計師事務所，對董事薪酬進行諮詢投票，以及批准2019年全面股權激勵計劃的修正案。董事會已建議贊成所有提案。截至2024年9月30日股東名冊上的股東有權參加並投票參與會議，由於無法親自出席，會議將在線上進行。代理材料，包括2024年年度報告和代理聲明，將在biovie的網站上提供，並於2024年10月9日左右寄給股東。
biovie公司，一家內華達州註冊公司，宣佈向證券交易委員會提交了一份預先14A初步代理聲明，詳細介紹了定於2024年11月7日舉行的即將召開的股東年會。會議將討論選舉六名董事，確認EisnerAmper LLP爲2025財年的獨立註冊會計師事務所，對董事薪酬進行諮詢投票，以及批准2019年全面股權激勵計劃的修正案。董事會已建議贊成所有提案。截至2024年9月30日股東名冊上的股東有權參加並投票參與會議，由於無法親自出席，會議將在線上進行。代理材料，包括2024年年度報告和代理聲明，將在biovie的網站上提供，並於2024年10月9日左右寄給股東。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間